The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH
Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia
Sponsor: Canadian Institutes of Health Research (CIHR)
A PHASE1 clinical study on Idiopathic Infantile Hypercalcemia - Mild Form, this trial is ongoing. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Sep 2021 — Sep 2023 [monthly]
Recruiting PHASE1
Status: Unknown Status → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status PHASE1
▶ Show 3 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE1
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Children's Hospital of Philadelphia
- Cures Within Reach
- The Hospital for Sick Children
For direct contact, visit the study record on ClinicalTrials.gov .